Search research articles
Contact Us
Filters
Showing results (191-200 of 271) with videos related to
Page
of 28
Sort By:
European Urology
|
August 25, 2005
Stress incontinence injection therapy: what is best for our patients?
Christopher R Chapple, Alan J Wein, Linda Brubaker, et al.
Neurourology and Urodynamics
|
November 25, 2024
Development of a Clinically Relevant Preclinical Animal Model to Mimic Suburethral Implantation of Support Materials for Stress Urinary Incontinence
Christopher R Chapple, Raouf Seyam, Omar Alsulaiman, et al.
European Urology Focus
|
March 5, 2020
A Systematic Review of Surgical interventions for the Treatment of Bladder Pain Syndrome/Interstitial Cystitis
Nadir I Osman, David G Bratt, Alison P Downey, et al.
European Urology
|
December 6, 2020
The Modified Prone Jack-knife Position for the Excision of Female Urethral Diverticula
Nadir I Osman, Naside Mangir, Felicity A Reeves, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
April 9, 2019
The use of laser as a therapeutic modality as compared to TURP for the small prostate ≤40 mL: a collaborative review
Sebastiano Rapisarda, Giorgio I Russo, Nadir I Osman, et al.
European Urology
|
May 9, 2017
Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence
Ferdinando Fusco, Mohamed Abdel-Fattah, Christopher R Chapple, et al.
European Urology
|
December 1, 2012
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder
Christopher R Chapple, Steven A Kaplan, David Mitcheson, et al.
European Urology
|
December 28, 2007
Cholinergic innervation and muscarinic receptors in the human prostate
Lambertus P W Witte, Christopher R Chapple, Jean J M C H de la Rosette, et al.
European Urology
|
October 23, 2019
Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo
Christopher R Chapple, Francisco Cruz, Linda Cardozo, et al.
European Urology
|
February 16, 2017
Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice
Christopher R Chapple, Jameel Nazir, Zalmai Hakimi, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 271) with videos related to
Sort By:
Page
of 28
European Urology
|
August 25, 2005
Stress incontinence injection therapy: what is best for our patients?
Christopher R Chapple, Alan J Wein, Linda Brubaker, et al.
Neurourology and Urodynamics
|
November 25, 2024
Development of a Clinically Relevant Preclinical Animal Model to Mimic Suburethral Implantation of Support Materials for Stress Urinary Incontinence
Christopher R Chapple, Raouf Seyam, Omar Alsulaiman, et al.
European Urology Focus
|
March 5, 2020
A Systematic Review of Surgical interventions for the Treatment of Bladder Pain Syndrome/Interstitial Cystitis
Nadir I Osman, David G Bratt, Alison P Downey, et al.
European Urology
|
December 6, 2020
The Modified Prone Jack-knife Position for the Excision of Female Urethral Diverticula
Nadir I Osman, Naside Mangir, Felicity A Reeves, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
April 9, 2019
The use of laser as a therapeutic modality as compared to TURP for the small prostate ≤40 mL: a collaborative review
Sebastiano Rapisarda, Giorgio I Russo, Nadir I Osman, et al.
European Urology
|
May 9, 2017
Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence
Ferdinando Fusco, Mohamed Abdel-Fattah, Christopher R Chapple, et al.
European Urology
|
December 1, 2012
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder
Christopher R Chapple, Steven A Kaplan, David Mitcheson, et al.
European Urology
|
December 28, 2007
Cholinergic innervation and muscarinic receptors in the human prostate
Lambertus P W Witte, Christopher R Chapple, Jean J M C H de la Rosette, et al.
European Urology
|
October 23, 2019
Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo
Christopher R Chapple, Francisco Cruz, Linda Cardozo, et al.
European Urology
|
February 16, 2017
Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice
Christopher R Chapple, Jameel Nazir, Zalmai Hakimi, et al.
Page
of 28